Between 1981 and 1985, a total of 289 patients were seen at our anticoagulation clinic. Two
hundred and forty-seven received long-term oral anticoagulation therapy because of a …

Objective To describe the Registry and report preliminary data for the prevalence of 5
prothrombotic gene mutations in the normal Saudi population. Methods Blood from consenting …

Objective To determine the prevalence of CYP2C9 polymorphism in normal Saudis (controls),
in Saudi patients with venous thrombosis, in patients requiring low dose warfarin (study …

PURPOSE: To investigate the association of FVL, prothrombin G20210A and MTHFR
C677T mutations in patients with thrombosed Prosthetic Heart Valves and intracardiac clots. …

To describe the Registry and report preliminary data for the prevalence of 5 prothrombotic
gene mutations in the normal Saudi population. Blood from consenting healthy Saudi …

To determine the prevalence of CYP2C9 polymorphism in normal Saudis [controls], in Saudi
patients with venous thrombosis, in patients requiring low dose warfarin [study group] for …

To the Editor: The work of Saour et al. on anticoagulation in patients with prosthetic heart
valves (Feb. 15 issue) 1 is to be commended for its attempt to address the problem of the …

We compared the efficacy and complications of anticoagulation with warfarin in 258 patients
with prosthetic heart valves treated with regimens of "moderate intensity" (prothrombin-time …

Between 1981 and 1985, a total of 289 patients were seen at our anticoagulation clinic. Two
hundred and forty-seven received long-term oral anticoagulation therapy because of a …

… Jalal Saour … Jalal Saour … Mammo L, Sheereen A, Saour T, Shoukri M, Saour J. "Incidence
of five prothrombotic gene polymorphism in healthy Saudi Arabians" . J Thromb Haemost. …